Elsevier, a global leader in research publishing and information analytics, will host an upcoming series of webinars produced in partnership with The Lancet Infectious Diseases, which is part of the highly respected The Lancet family of journals. The first webinar will take place April 28th during World Immunization Week (April 24-30) to help demystify the COVID-19 vaccines for the general public and will include live translations in French, Spanish, Portuguese, Italian, German, Polish and Russian.
The first webinar with John McConnell, Editor-in-Chief of The Lancet Infectious Diseases, will address how the vaccines work, reviewing the data on their safety and efficacy in preventing disease. The second webinar will be geared toward medical and research professionals, highlighting the science behind the vaccines’ development.
Since the start of the pandemic, Elsevier has played a significant role helping support the healthcare community combat the virus that causes COVID-19. In April 2020, Elsevier launched the COVID-19 Healthcare Hub, which provides fact-based resources for healthcare professionals, working on the frontlines of the pandemic. In addition to sharing the latest medical information, approved treatments and guidelines and other valuable tools, the healthcare community also have access to an ICU Nurses Refresher Toolkit and a COVID-19 Vaccine Toolkit, with specific information for global nurses working with ICU patients and information on the available COVID-19 vaccines.
Details on each of the free webinars are:
Demystifying COVID-19 Vaccines: Wednesday, April 28, 2021 at 10:00 AM ET / 3:00 PM BST / 4:00 PM CEST; available for free to the general public (via Zoom). Live translations to be provided in French, Spanish, Portuguese, Italian, German, Polish and Russian.
John McConnell, Editor-in-Chief of The Lancet Infectious Diseases, and Ylann Schemm, Director of the Elsevier Foundation and Corporate Responsibility at Elsevier, will participate in a discussion about the science behind COVID-19 vaccines, and the latest insights from safety and efficacy data. McConnell will also address the public’s most frequently asked questions on vaccine importance, safety, efficacy, re-infection, and the currently known COVID-19 variants. Interested parties may register here.
COVID-19 Vaccines: An Update on Research & Global Availability: Wednesday, May 12, 2021 at 10:00 AM ET / 3:00 PM BST / 4:00 PM CEST; available to biomedical scientists via Elsevier’s Researcher Academy on Campus portal.
John McConnell, Editor-in-Chief of The Lancet Infectious Diseases, will discuss vaccine effectiveness in preventing disease, address safety concerns with vaccine side effects (e.g., reactogenicity, anaphylaxis, clotting disorders, Bell's palsy), information on global availability, and the evolution of the research landscape in light of the pandemic.
Click here to read the original press release.
